Latest Industry News & Trends

Market Scope provides comprehensive coverage of the ophthalmic and orthopedic markets. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with companies executive. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic or orthopedic industry newsletters.

Ophthalmic Orthopedic

Recently Added ophthalmic

OphthalmicPress Release
Safer and More Effective Glaucoma Surgical Options Will Drive Surgery Device Treatment Penetration Over Next Five Years

Expanding use of surgical devices in patients with all stages of glaucoma will increase the role of surgery in the glaucoma treatment paradigm over the next five years. There are four FDA-approved ...

AAO, ASCRS Ask Congress to Prevent 6 Percent Reduction in Ophthalmologists’ Fees

The American Academy of Ophthalmology (AAO) and American Society of Cataract and Refractive Surgery (ASCRS) have asked Congress to prevent the latest proposed cuts in Medicare reimbursement to opht...

US FDA Accepts Clearside’s IND Application for Axitinib Suprachoroidal Injection

Clearside Biomedical announced Aug. 10 that the US FDA had accepted its investigational new drug (IND) application for CLS-AX (axitinib injectable suspension) for wet age-related macular degenerati...

Avellino Hits Milestone of 1 Million Genetic Tests

Avellino announced Aug. 13 that the company has topped 1 million genetic and molecular diagnostic tests. The Menlo Park, California, company said the milestone includes more than 821 thousand AvaGe...

BreakingGene TherapyOphthalmicRegulationRetina
Ocugen Gets Fourth Orphan Drug Designation for OCU400 Gene Therapy Candidate

Ocugen, of Malvern, Pennsylvania, announced Aug. 10 that the US FDA had granted its fourth orphan drug designation for OCU400, this one for the treatment of PDE6B gene mutation-associated retinal d...

Eyenovia, Arctic Vision Team Up to Commercialize MicroPine, MicroLine in Greater China, South Korea

Eyenovia, of New York, and China’s Arctic Vision announced Aug. 11 that they had entered into an exclusive license agreement for Arctic Vision to develop and commercialize MicroPine for progressive...

Amydis Gets New Michael J. Fox Foundation Grant to Diagnose Parkinson’s Through Retina

Amydis, of San Diego, announced Aug. 11 that it had received a new grant from the Michael J. Fox Foundation for Parkinson’s Research for the company’s pioneering retinal tracer program for alpha-sy...

Omeros Expects to Net $297.4 Million in Two Public Offerings

Omeros, of Seattle, announced Aug. 12 that it had priced concurrent underwritten public offerings of 6.9 million shares of its common stock at $14.50 per share, for proceeds of approximately $100 m...

TearClear Raises $22 Million in Series B Funding

TearClear, of Boston, announced Aug. 11 that it had raised $22 million in a Series B funding round. The company said the investment will be used to advance multiple clinical programs, with two lead...

Bausch Health to Spin Out Bausch + Lomb to Separate Publicly Traded Company

Canada-headquartered Bausch Health Companies announced Aug. 6 that it plans to spin off Bausch + Lomb into a separate publicly traded company. The new entity will be called Bausch + Lomb—NewCo and ...

Q2-2020 Earnings: Ocular Therapeutix, Aerie, Bausch + Lomb, LENSAR, Six More

Ocular Therapeutix reported Aug. 7 that its Q2-2020 net product revenue was $1.6 million, with $1.4 million for Dextenza and $0.2 million for ReSure Sealant. The company had revenue of $650 thousan...

EyePoint, ImprimisRx Join Forces to Promote Dexycu in the US

EyePoint Pharmaceuticals and ImprimisRx announced Aug. 4 that they had formed a commercial alliance for the joint promotion in the US of Dexycu (dexamethasone intraocular suspension) 9% for the tre...

Past News Stories

Surgeon’s 15-Second UVC Treatment for Corneal Infections Wins 2020 Winning Pitch Challenge

Sunil Shah, MD, of the UK, won the 2020 Winning Pitch Challenge with a UVC device candidate he co-invented to treat corneal infections. He represented Photon Therapeutics and its team of five in th...

Lumibird Acquires Scandinavian Distributor EssMed

French laser company Lumibird announced Aug. 3 that it had acquired EssMed, one of its distribution companies. EssMed operates in Sweden, Finland, and Norway, with revenue of around €2 million (US ...

Eyenuk Gains FDA Clearance for EyeArt Autonomous AI for DR Screening

Eyenuk announced Aug. 5 that it had received 510(k) clearance from the US FDA to market its EyeArt autonomous AI system for diabetic retinopathy (DR). Eyenuk, of Woodland Hills, California, says it...

BreakingDealsDry EyeOphthalmicPharma
Iacta, Led by Former Allergan Execs, to Collaborate with Zhaoke on Two Eye Candidates

Irvine, California-based Iacta Pharmaceuticals will co-develop two of its ophthalmic drug candidates with Hong Kong’s Zhaoke Ophthalmology Pharmaceutical Limited, a subsidiary of Lee's Pharmace...

Eurazeo China Acceleration Fund Invests €80 Million in DORC

Paris-based Eurazeo announced July 27 that its Eurazeo China Acceleration Fund made an €80 million investment in Dutch Ophthalmic Research Center (DORC) as its first backing. DORC is a portfolio co...

Retina-AI Health Raises $5.2 Million in Series A Financing for its for AI Detection of DR

Retina-AI Health, of Houston, announced Aug. 6 that it had raised $5.2 million in a Series A financing for its AI screening of diabetic retinopathy. The company said the capital was raised from pri...

iOR Partners Adds Tom Frinzi to Board

iOR Partners, the Kansas City company pioneering office-based surgery in ophthalmology, announced July 29 that industry veteran Tom Frinzi had joined its board of directors. Daniel Durrie, MD, iOR ...

Oxurion Appoints Grace Chang, MD, PhD, as Chief Medical Officer

Belgian company Oxurionannounced Aug. 3 that it had appointed Grace Chang, MD, PhD, as the company’s chief medical officer. Chang is a practicing vitreoretinal surgeon with deep expertise in ophtha...

DiagnosticOphthalmicPress Release
Diagnostic Market Sees New Demand Due to Effects of COVID-19

Increasing demand for telehealth and mobile applications due to the COVID-19 pandemic has led manufacturers to scramble to add functionality and accessibility to existing devices and protection app...

Q2-2020 Ophthalmic Company Earnings: Alimera, Hoya, Lumibird, Roche, Novartis, J&J Vision

Atlanta-based Alimera Sciences announced July 29 that its net revenue in Q2-2020 was $10.0 million, a drop of 8 percent from $10.9 million in Q2-2019. Revenue outside the US increased 89 percent, t...

VSY Biotechnology Launches Dry-Packed IOL Designed to be Glistening Free

VSY Biotechnology launched its Enova intraocular lens on July 22. The Germany-based company said Enova is designed to be the first glistening-free hydrophobic acrylic IOL that does not require pre-...

Vesigen Launches with $28.5 Million Series A Financing to Develop Drug Delivery Technology from Harvard

Harvard University announced July 22 the launch of Vesigen Therapeutics, of Cambridge, Massachusetts, a startup company that aims to improve delivery of next-generation therapeutics. A $28.5 millio...

Want to Read the Full Article?

Register A Corporate Account

A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.

Select one or more
Select one or more

Market Scope

13421 Manchester Road, Suite 201 | St. Louis, MO 63131 | Phone: 314-835-0600 | Email:

©2020 Market Scope, LLC. All Rights reserved.